-
Extent and Causes of the Collapse in the Registration of Innovative Medications in Lebanon: A Mixed-Methods Analysis
Sep 9, 2025, 16:22 PM -
Improving Indirect Treatment Comparisons via an Alternative MAIC Patient Weighting Method
Sep 9, 2025, 16:22 PM -
Evaluating the Use of Large Language Models (LLM) in Summarizing Treatment Guidelines: A Pilot Study
Sep 9, 2025, 16:22 PM -
Severity of COVID-19 Pre- and Post-Omicron Emergence in Pediatric Patients: A Global Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Trends in Antiviral Drug Cost Proportion Under Different HBV Coverage Targets in China: A 2024-2050 Modeling Study
Sep 9, 2025, 16:22 PM -
Changes in the Epidemiological Indicators of Female Infertility in Europe 1991-2021
Sep 9, 2025, 16:22 PM -
Unlocking Value Early: Insights Into NICE’s Early Value Assessments and Evidence-Generation Plans for Medical Technologies
Sep 9, 2025, 16:22 PM -
Navigating HTA and Innovation: Oncologists’ Perspectives on Access to Cancer Therapies in Bulgaria
Sep 9, 2025, 16:22 PM -
Cost and Healthcare Resource Implications of PARP Inhibitor Therapy for BRCA-Mutated Ovarian Cancer: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Inclisiran for the Management of Patients With Atherosclerotic Cardiovascular Disease in India: A Multipayer Analysis
Sep 9, 2025, 16:22 PM -
Genomic Testing for Early Breast Cancer: Assessing the Value of Next-Generation Sequencing
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization and Costs Among Bacillus Calmette-Guérin (BCG)-Experienced or Unresponsive Patients With Papillary-Only High-Risk Non–Muscle Invasive Bladder Cancer
Sep 9, 2025, 16:22 PM -
Bimekizumab Cost per Responder Analysis Compared to Other Licensed Interleukin Inhibitors at Week 52 for the Treatment of Psoriatic Arthritis: A United Kingdom Perspective
Sep 9, 2025, 16:22 PM -
A Randomized Trial of the CARE -KOA’s© Efficacy on Ultrasound Measured Femoral Cartilage Thickness and Quality of Life in Knee Osteoarthritis Patients
Sep 9, 2025, 16:22 PM -
The Innovative Licensing and Access Pathway (ILAP): Early Pathway Experience, Examining, Process Adaptations, and Industry Impact
Sep 9, 2025, 16:22 PM -
The Socioeconomic Burden of Dengue in Spain
Sep 9, 2025, 16:22 PM -
Optimizing a New Patient-Reported Outcome Instrument for Proliferative Diabetic Retinopathy: A Psychometric Study
Sep 9, 2025, 16:22 PM -
Economic Impact of Incorporating a Fecal Bacterial Signature to Optimize FIT-Based Colorectal Cancer Screening in Spain
Sep 9, 2025, 16:22 PM -
Development of an AI-Powered Tool to Accelerate and Enhance Systematic Literature Reviews for Evidence-Based Decision Making in Clinical Research
Sep 9, 2025, 16:22 PM -
Linking Data to Care: Mining the Pathways of Oncology
Sep 9, 2025, 16:22 PM